Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003456 · ClinicalTrials.gov registry record · Early Phase 1
Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging
A Early Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT02003456 is a Early Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 30 participants.
The verdict
NCT02003456, a Early Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Positron emission tomography (PET) scans can be used to evaluate whether parts of the heart muscle are alive but receiving inadequate blood supply. This study involves the use of two radiotracers that will measure whether heart muscle cell are alive and quantify the blood supply to the heart muscle.
Interventions
- DRUG Cardiac PET scan w/18F-Fluorodeoxyglucose and rubidium-82
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02003456
The ClinicalTrials.gov registry entry for NCT02003456 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac PET scan w/18F-Fluorodeoxyglucose and rubidium-82 is the first listed.
NCT02003456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02003456 about?
NCT02003456 is a clinical study titled "Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging". Positron emission tomography (PET) scans can be used to evaluate whether parts of the heart muscle are alive but receiving inadequate blood supply. This study involves the use of two radiotracers that will measure whether heart muscle cell are alive and quantify the blood supply to the heart muscle.
What is the current status of trial NCT02003456?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2013-12. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02003456?
The interventions under investigation include: Cardiac PET scan w/18F-Fluorodeoxyglucose and rubidium-82 (DRUG).
Who is sponsoring clinical trial NCT02003456?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.